Advanced manufacturing technology in the here and now.
Recognizing that additive manufacturing is an emerging technology, the agency is providing an outline of its current thinking about the technical aspects of AM processes.
With the largest patient population in the world, the region has high growth potential over the next few years.
The agency addresses design and manufacturing considerations, along with device submissions for product approval.
The rise in chronic disease and the effort to reduce healthcare costs presents a large opportunity for the field of regenerative medicine.
While the terms rapid prototyping, additive manufacturing, and 3-D printing are used interchangeably these days, biofabrication is setting itself apart.
Design freedom, increased accuracy, and customization, are fueling growth.
For 3D printing to thrive in the medical device space, the use of biomaterials must be expanded.
The University of Central Florida and Limbitless Solutions partner to develop the technology and move it into commercialization.
As additive manufacturing comes to the forefront as a disruptive technology, industry continues to speculate about how liability will be shared.